Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory C McDermott

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
ACR Open Rheumatology|December 2, 2025
The "Clinical Topics" from the Electronic Health Record of Patients with Rheumatoid Arthritis Before Initiating Targeted Therapies and Association with Future Treatment CourseJason Tang, Dana Weisenfeld, Linshanshan Wang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 25, 2025
Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis: A comparative cohort studyQianru Zhang, Ying Qi, Xiaosong Wang, et al.
Rheumatology (Oxford, England)|July 11, 2025
Risk of total and cause-specific mortality in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasisQianru Zhang, Ying Qi, Xiaosong Wang, et al.
Current Treatment Options in Rheumatology|January 17, 2025
Treatment of rheumatoid arthritis-associated interstitial lung disease: An appraisal of the 2023 ACR/CHEST guidelineAlene A Saavedra, Kevin T Mueller, Emily N Kowalski, et al.
Seminars in Arthritis and Rheumatism|May 13, 2026
Hospitalization risk in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis: A matched cohort studyQianru Zhang, Ying Qi, Xiaosong Wang, et al.
The Journal of Rheumatology|December 1, 2025
Screening for rheumatoid arthritis-associated interstitial lung disease: Current evidence and next steps needed for routine clinical useLauren A O'Keeffe, Liya Sisay Getachew, Suchita P Nety, et al.
Seminars in Arthritis and Rheumatism|August 18, 2023
Gene-respiratory disease interactions for rheumatoid arthritis riskVanessa L Kronzer, Keigo Hayashi, Cynthia S Crowson, et al.
Arthritis Care & Research|December 9, 2024
Risk of Incident Heart Failure and Heart Failure Subtypes in Patients With Rheumatoid ArthritisYumeko Kawano, Brittany N Weber, Dana Weisenfeld, et al.
Seminars in Arthritis and Rheumatism|March 8, 2024
Reasons for multiple biologic and targeted synthetic DMARD switching and characteristics of treatment refractory rheumatoid arthritisGregory C McDermott, Michael DiIorio, Yumeko Kawano, et al.
Seminars in Arthritis and Rheumatism|October 16, 2024
Disease-modifying antirheumatic drugs and risk of incident interstitial lung disease among patients with rheumatoid arthritis: A systematic review and meta-analysisQianru Zhang, Gregory C McDermott, Pierre-Antoine Juge, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
ACR Open Rheumatology|December 2, 2025
The "Clinical Topics" from the Electronic Health Record of Patients with Rheumatoid Arthritis Before Initiating Targeted Therapies and Association with Future Treatment CourseJason Tang, Dana Weisenfeld, Linshanshan Wang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 25, 2025
Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis: A comparative cohort studyQianru Zhang, Ying Qi, Xiaosong Wang, et al.
Rheumatology (Oxford, England)|July 11, 2025
Risk of total and cause-specific mortality in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasisQianru Zhang, Ying Qi, Xiaosong Wang, et al.
Current Treatment Options in Rheumatology|January 17, 2025
Treatment of rheumatoid arthritis-associated interstitial lung disease: An appraisal of the 2023 ACR/CHEST guidelineAlene A Saavedra, Kevin T Mueller, Emily N Kowalski, et al.
Seminars in Arthritis and Rheumatism|May 13, 2026
Hospitalization risk in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis: A matched cohort studyQianru Zhang, Ying Qi, Xiaosong Wang, et al.
The Journal of Rheumatology|December 1, 2025
Screening for rheumatoid arthritis-associated interstitial lung disease: Current evidence and next steps needed for routine clinical useLauren A O'Keeffe, Liya Sisay Getachew, Suchita P Nety, et al.
Seminars in Arthritis and Rheumatism|August 18, 2023
Gene-respiratory disease interactions for rheumatoid arthritis riskVanessa L Kronzer, Keigo Hayashi, Cynthia S Crowson, et al.
Arthritis Care & Research|December 9, 2024
Risk of Incident Heart Failure and Heart Failure Subtypes in Patients With Rheumatoid ArthritisYumeko Kawano, Brittany N Weber, Dana Weisenfeld, et al.
Seminars in Arthritis and Rheumatism|March 8, 2024
Reasons for multiple biologic and targeted synthetic DMARD switching and characteristics of treatment refractory rheumatoid arthritisGregory C McDermott, Michael DiIorio, Yumeko Kawano, et al.
Seminars in Arthritis and Rheumatism|October 16, 2024
Disease-modifying antirheumatic drugs and risk of incident interstitial lung disease among patients with rheumatoid arthritis: A systematic review and meta-analysisQianru Zhang, Gregory C McDermott, Pierre-Antoine Juge, et al.
Pageof 5